Stephan Jansen

Partnering, Licensing, Consulting

Stephan is the managing director of Pronex GmbH, an M&A and Business Development advisory boutique for Life Science (Pharma, Biotech, Med-Tech, and Healthcare) and Information Technology.

Stephan spent 12 years in the Pharma and Healthcare Industry before becoming an entrepreneur. He worked for F. Hoffmann-La Roche in Basel where he held operational roles in Production, Quality Management and Regulatory, as well as strategic positions in Corporate Finance and M&A.

After 4 years with Fresenius SE in Bad Homburg as VP M&A and Business Development, where he lead national and international M&A projects for the Fresenius group and was responsible for the development and execution of acquisition, divestment and licensing opportunities, he decided to become independent and founded Pronex GmbH.

Stephan can look back to over 100 M&A and BD deals, in Europe, the Americas, Asia and emerging markets. He holds a Master in Biology from the University of Konstanz, Germany with majors in Genetics, Protein Biology and Bio-Informatics. He also holds an MBA from the University of Srathclyde, Scotland with majors in strategy, entrepreneurship and finance.

Pronex GmbH offers M&A as well as partnering and licensing support. Further services include strategy consulting with a focus on new markets entries and internationalization. Pronex is also active in negotiation support and negotiation training.